This inventor holds 1 USPTO granted patent. Top assignee: Norgine Bv. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Edwin Aret: Innovator in Benzoxazinone Compounds
Introduction: Edwin Aret is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the prevention and treatment of obesity. His innovative work has led to the creation of a unique crystal form of a benzoxazinone compound.
Latest Patents: Edwin Aret holds a patent for a crystal of 2-(hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one. This compound is disclosed as a preventive or therapeutic agent for obesity and similar conditions. The patent specifically describes a crystal form that exhibits a powder X-ray diffraction pattern with characteristic peaks at interplanar spacings (d) of approximately 16.54±0.2, 13.26±0.2, 4.70±0.2, 4.38±0.2, and 3.67±0.2 Å. This innovation highlights the potential of benzoxazinone compounds in addressing significant health issues.
Career Highlights: Edwin Aret has established himself as a key figure in the pharmaceutical industry. His work at Norgine Bv has allowed him to focus on the development of therapeutic agents that can have a meaningful impact on public health. His dedication to research and innovation has positioned him as a valuable contributor to the field.
Collaborations:
Conclusion: Edwin Aret's contributions to the field of medicinal chemistry, particularly through his patent on benzoxazinone compounds, demonstrate his commitment to innovation and public health. His work continues to inspire advancements in therapeutic solutions for obesity and related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile